SAFE vs Convertible Note

Definition

A SAFE (Simple Agreement for Future Equity) is a contractual right to receive equity in a future priced round without creating debt, accruing interest, or having a maturity date — invented by Y Combinator in 2013. A convertible note is a short-term debt instrument that converts to equity at a future priced round, carrying interest (typically 2-8% annually) and a maturity date (12-24 months). Both instruments defer company valuation to a future round and use valuation caps and/or discounts to reward early investors. [src1]

Key Properties

Legal nature: SAFE is equity-like (not debt); convertible note is debt that converts to equity
Interest: SAFEs accrue no interest; convertible notes accrue 2-8% annually, added to principal at conversion
Maturity date: SAFEs have none; convertible notes mature in 12-24 months
Closing speed: SAFEs close in ~1.8 weeks; convertible notes take ~4.2 weeks
Market share (2024): 88% of pre-priced rounds use SAFEs
Valuation cap: Both can include a cap — max valuation at which investment converts
Discount rate: Both typically include a 15-25% discount on next round price per share

Constraints

SAFEs have limited legal recognition outside the US — convertible notes may be required [src1]
Stacking multiple SAFEs without tracking creates dilution surprises at conversion [src2]
Convertible note maturity creates legal risk — noteholders can demand repayment [src4]
Neither instrument establishes a company valuation [src3]
Interest rates on convertible notes rose 200-300 bps in 2024-2025 [src2]

Framework Selection Decision Tree

START — Founder needs pre-seed/seed funding
├── Is the company incorporated in the US (Delaware C-Corp)?
│   ├── YES → SAFE is the default instrument (88% market share)
│   └── NO → Check local jurisdiction; convertible note may be required
├── What's the investor preference?
│   ├── Angels / accelerators → SAFE (faster, simpler, no maturity risk)
│   ├── Institutional seed → SAFE with cap + discount (or priced round)
│   └── Bridge between rounds → Convertible note (debt priority)
├── Is there a near-term priced round expected?
│   ├── YES (< 6 months) → Either works; SAFE is faster
│   └── NO (> 12 months) → SAFE preferred (no maturity default risk)
└── Does the investor require interest accrual?
    ├── YES → Convertible note ← REQUIRED
    └── NO → SAFE ← YOU ARE HERE (most cases)

Application Checklist

Step 1: Choose the instrument

Inputs needed: Jurisdiction, investor type, expected timeline to priced round
Output: Decision: SAFE or convertible note
Constraint: Verify SAFE enforceability in your jurisdiction [src1]

Step 2: Set the valuation cap

Inputs needed: Traction, comparable valuations, amount raised
Output: Cap amount (e.g., $8M cap for $1M raise)
Constraint: Avoid uncapped instruments — they compound dilution unpredictably [src2]

Step 3: Set the discount rate

Inputs needed: Investor return expectations, time to conversion, market norms
Output: Discount percentage (typically 15-25%)
Constraint: Model both cap and discount scenarios — investors get the more favorable [src3]

Step 4: Model conversion scenarios

Inputs needed: SAFE/note amount, cap, discount, expected Series A valuation, option pool
Output: Pro-forma cap table showing post-conversion ownership
Constraint: Always model worst case where Series A valuation far exceeds cap [src5]

Anti-Patterns

Wrong: Raising multiple uncapped SAFEs assuming minimal dilution

Founders who raise 3-4 uncapped SAFEs discover at Series A that uncapped instruments convert at the Series A price, giving early investors far more equity than expected. [src2]

Correct: Always include a valuation cap and model cumulative dilution

Set a cap on every SAFE, then model what happens when all convert at the next round. [src3]

Wrong: Ignoring convertible note maturity dates

When a priced round stalls, noteholders can legally demand repayment, potentially forcing bankruptcy or fire-sale terms. [src4]

Correct: Negotiate extension provisions upfront

Include an automatic extension clause or use a SAFE to avoid maturity risk entirely. [src1]

Common Misconceptions

Misconception: SAFEs are "free money" because they are not debt and have no maturity date.
Reality: SAFEs always convert, diluting founders at the next priced round. The absence of a maturity date does not reduce their economic impact. [src3]

Misconception: A valuation cap means the company is valued at that amount today.
Reality: A cap is a ceiling on conversion price, not a valuation. [src1]

Misconception: Interest on convertible notes is paid in cash.
Reality: Interest accrues and is added to the principal at conversion. A $500K note at 6% for 18 months converts as ~$545K of equity. [src4]

Comparison with Similar Concepts

Concept	Key Difference	When to Use
SAFE	Equity-like, no debt, no maturity, no interest	Default for US pre-seed/seed; fastest to close
Convertible Note	Debt instrument with interest + maturity date	Bridge rounds, international, when debt status needed
Priced Equity Round	Sets a fixed valuation and price per share	Series A and beyond; sufficient traction to price
Revenue-Based Financing	Repaid as % of revenue, no equity conversion	When founders want to avoid dilution entirely

When This Matters

Fetch this when a founder asks about early-stage funding instruments, is comparing SAFEs to convertible notes, needs to understand valuation caps or discounts, or is deciding which instrument to use for a pre-seed or seed raise.